Valeant Pharmaceuticals reported $26.3B in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amgen AMGN:US USD 65.12B 1.42B
Ani Pharmaceuticals ANIP:US USD 739.11M 12.22M
Aurora Cannabis Inc ACB:CN CAD 1.17B 85.57M
Biogen BIIB:US USD 24.85B 227.2M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Canopy Growth Corp WEED:CN CAD 3.4B 115.26M
Catalent CTLT:US USD 10.2B 302M
Corcept Therapeutics CORT:US USD 533.26M 36.89M
Danaher DHR:US USD 84.35B 3.32B
Drreddys Laboratories RDY:US INR 309.3B 18.33B
Eli Lilly And LLY:US USD 47.46B 397.9M
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
Gilead Sciences GILD:US USD 62.56B 313M
Horizon Pharma HZNP:US USD 9.03B 174.39M
Lannett LCI:US USD 467.3M 17.14M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Perrigo Ordinary Shares PRGO:US USD 10.68B 242.1M
Phibro Animal Health PAHC:US USD 948.38M 16.68M
Prestige Brands PBH:US USD 3.68B 3.72M
Revance Therapeutics RVNC:US USD 711.59M 149.71M
Supernus Pharmaceuticals SUPN:US USD 1.69B 1.84M
Valeant Pharmaceuticals VRX:CN USD 26.3B 1.87B
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B
Zoetis ZTS:US USD 13.67B 96M